loading

Finanzdaten der Caribou Biosciences Inc-Aktie (CRBU)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
13.34%
2.667
2.353 2.077 2.024 3.464
Operating Expenses
11.00%
50.24
45.27 40.95 40.26 46.97
Benefits Costs and Expenses
100.00%
-
42.34 37.58 - -
Costs And Expenses
18.66%
50.24
42.34 37.58 40.26 46.97
Operating Income/Loss
10.87%
-47.58
-42.91 -38.88 -38.24 -43.50
Nonoperating Income/Loss
323.13%
-6.52
2.922 3.376 3.554 5.804
Income/Loss From Continuing Operations Before Tax
106.67%
2.667
-39.99 -35.50 2.024 -37.70
Income/Loss From Continuing Operations After Tax
35.28%
-54.10
-39.99 -35.49 -34.68 -37.70
Net Income/Loss
35.28%
-54.10
-39.99 -35.49 -34.68 -37.70
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.38%
93.03
92.68 0.2831 90.46 90.34
Diluted Average Shares
0.38%
93.03
92.68 0.2831 90.46 90.34
Basic Earnings Per Share
34.88%
-0.58
-0.43 -0.39 -0.38 -0.42
Diluted Earnings Per Share
34.88%
-0.58
-0.43 -0.39 -0.38 -0.42
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$86.64
price up icon 1.40%
$27.54
price up icon 0.58%
$25.98
price up icon 9.16%
$112.46
price up icon 8.66%
$145.10
price up icon 1.80%
biotechnology ONC
$341.80
price up icon 7.24%
Kapitalisierung:     |  Volumen (24h):